Show Summary Details
Page of


Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 26 June 2022

Chapter 12: Psychiatry

1 Polonius. In: Shakespeare W. The Tragedy of Hamlet, Prince of Denmark.

2 Harris GT et al. Prospective replication of the Violence Risk Appraisal Guide in predicting violent recidivism among forensic patients. Law and Human Behavior 26.4 (2002):377–394. PubMed ID: 12182529.

3 Rogers R. The uncritical acceptance of risk assessment in forensic practice. Law and Human Behavior 24.5 (2000):595–605.

4 Kumar S et al. Application of risk assessment for violence methods to general adult psychiatry: a selective literature review. Australian and New Zealand Journal of Psychiatry 39.5 (2005):328–335.–1614.2005.01579.x

5 Hartvig P et al. Brief checklists for assessing violence risk among patients discharged from acute psychiatric facilities: a preliminary study. Nordic Journal of Psychiatry 60.3 (2006):243–248.

6 Carroll A. Are violence risk assessment tools clinically useful? Australian and New Zealand Journal of Psychiatry 41.4 (2007):301–307.

7 Lincoln TM. Relevant dimensions of delusions: continuing the continuum versus category debate. Schizophrenia Research 93.1 (2007):211–220.

8 Sims A. Symptoms in the Mind. London: Saunders; 1995.Find this resource:

9 The Economist. Living a second life. The Economist 28 September 2006.

10 Colman EAM. Squibb academic lecture: Shakespeare and DSM-III. Australasian Psychiatry 20.1 (1986):30–36.

11 Hellerstein DJ et al. Integrating services for schizophrenia and substance abuse. Psychiatric Quarterly 72.4 (2001):291–306.

12 Jeffery D et al. Treatment programmes for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews 2 (2000):CD001088.

13 Browne G et al. Economic evaluations of community-based care: lessons from twelve studies in Ontario. Journal of Evaluation in Clinical Practice 5.4 (1999):367–385.

14 Rosenheck RA et al. Cost-effectiveness of intensive psychiatric community care for high users of inpatient services. Archives of General Psychiatry 55.5 (1998):459–466.

15 Maden A et al. Offending in psychiatric patients after discharge from medium secure units: prospective national cohort study. BMJ 328.7455 (2004):1534.

16 Dieterich M, Irving CB, Park B, Marshall M. Intensive case management for severe mental illness. Cochrane Database of Systematic Reviews 10 (2010).

17 Marshall M et al. Assertive community treatment for people with severe mental disorders. The Cochrane Library (2011).

18 Petersen L et al. A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness. BMJ 331.7517 (2005):602.

19 Wiersma D et al. Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophrenia Bulletin 24.1 (1998):75.

20 Mueser KT et al. Schizophrenia. The Lancet 363 (2004):2063–2072.

21 van Os J et al. Schizophrenia. The Lancet 374 (2009):635–645.

22 Kramlinger KG et al. Adding lithium carbonate to carbamazepine: antimanic efficacy in treatment-resistant mania. Acta Psychiatrica Scandinavica 79.4 (1989):378–385.

23 Miller DS et al. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania. Journal of Clinical Psychiatry 62.12 (2001):975–980.

24 Tohen M et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Archives of General Psychiatry 59 (2002):62–69.

25 Sachs GS et al. The expert consensus guideline series: medication treatment of bipolar disorder. Postgraduate Medicine 1 (2000):1–104.

26 Compton MT et al. The treatment of bipolar depression. Journal of Clinical Psychiatry 61 (2000):57–67.

27 Mukherjee S et al. Electroconvulsive therapy of acute manic episodes: a review of 50 years’ experience. American Journal of Psychiatry 151.2 (1994):169–176.

28 Sarris J et al. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. The Journal of Clinical Psychiatry 73.1 (2012):81–86.

29 Wiersma D et al. Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophrenia Bulletin 24.1 (1998):75.

30 Mueser KT et al. Schizophrenia. The Lancet 363 (2004):2063–2072. PubMed ID: 15207959.

31 BioMedicine. ‘Schizophrenia’ term ought to be abolished.

32 Stefansson H et al. Neuregulin I and susceptibility to schizophrenia. American Journal of Human Genetics 71 (2002):877–892.

33 Straub RE et al. Genetic variation in the 6p22 gene DTNBPI, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. American Journal of Human Genetics 71 (2002):337–348.

34 Caspi A et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene x environment interaction. Biological Psychiatry 57.10 (2005):1117–1127. PubMed ID: 15866551.

35 Murray R. New ways of thinking about and treating psychosis. Keynote lecture. Progress in Neurology and Psychiatry 8.8 (2004):20–26.

36 Andreasson S et al. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. The Lancet 2 (1987):1483–1486

37 Arseneault L et al. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 325 (2002):1212–1213.

38 Jones P et al. Child development risk factors for adult schizophrenia in the British 1946 cohort. The Lancet 344 (1994):1398–1402.

39 Jones P et al. Schizophrenia as a long-term outcome of pregnancy, delivery and perinatal complications: a 28-year follow-up of the 1966 north Finland general population cohort. American Journal of Psychiatry 155.3 (1998):355–364.

40 Boos HB et al. Brain volumes in relatives of patients with schizophrenia: a meta-analysis. Archives of General Psychiatry 64.3 (2007):297–304. PubMed ID: 17339518.

41 Puri BK et al. Revision Notes in Psychiatry (2nd ed). London: Arnold; 2002, 377–378.Find this resource:

42 Dorph-Petersen KA et al. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 30.9 (2005):1649–1661. PubMed ID: 15756305.

43 Murray RM et al. A neurodevelopmental approach to the classification to schizophrenia. Schizophrenia Bulletin 18 (1992):319–332.

44 Murray RM. New ways of thinking about and treating psychosis. Keynote lecture. Progress in Neurology and Psychiatry 8.8 (2004):20–26.

45 Marshall M et al. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Archives of General Psychiatry 62.9 (2005):975–983.

46 Cant B. Exploring the implications for health professionals of men coming out as gay in healthcare settings. Health & Social Care in the Community 14.1 (2006):9–16.

47 Awad AG et al. The burden of schizophrenia on caregivers. Pharmacoeconomics 26.2 (2008):149–162.

48 Bressi C et al. Systemic family therapy in schizophrenia: a randomized clinical trial of effectiveness. Psychotherapy and Psychosomatics 77.1 (2008):43–49.

49 Morgan VA et al. Do women express and experience psychosis differently from men? Epidemiological evidence from the Australian National Study of Low Prevalence (Psychotic) Disorders. Australian and New Zealand Journal of Psychiatry 42.1 (2008):74–82.

50 Amos AJ. A review of spin and bias use in the early intervention in psychosis literature. The Primary Care Companion for CNS Disorders 16.1 (2014).

51 Bagnall A-M et al. A systematic review of atypical antipsychotic drugs in schizophrenia. Health Technology Assessment 37.13 (2003):1–193.

52 Davis JM et al. A meta-analysis of the efficacy of second generation antipsychotics. Archives of General Psychiatry 60 (2003):553–564. PubMed ID: 12796218.

53 Leucht S et al. Relapse prevention in schizophrenia with new-generation antipsychotic: a systematic review and exploratory meta-analysis of randomized controlled trials. American Journal of Psychiatry 160 (2003):1209–1222. PubMed ID: 12832232

54 Taylor M et al. ‘Do unto others as … ’ – which treatments do psychiatrists prefer? Scottish Medical Journal 52.1 (2007):17–19. PubMed ID: 17373419.

55 Burns T et al. Switching antipsychotic medications: general recommendations and switching to amisulpride. Current Medical Research and Opinion 18.4 (2002):201–208. PubMed ID: 12201620.

56 Suzuki T et al. Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophrenia. The International Journal of Neuropsychopharmacology 7.02 (2004):133–142.

57 Chan J et al. Combination therapy with non-clozapine atypical antipsychotic medication: a review of current evidence. Journal of Psychopharmacology 21.6 (2007):657–664. PubMed ID: 17092976.

58 Arvanitis LA et al. Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. Biological Psychiatry 42.4 (1997):233–246. PubMed ID: 9270900.

59 Volavka J et al. Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol. Journal of Clinical Psychiatry 65 (2004):57–61. PubMed ID: 14744169.

60 Costa AM et al. A naturalistic, 9-month follow-up, comparing olanzapine and conventional antipsychotics on sexual function and hormonal profile for males with schizophrenia. Journal of Psychopharmacology 21.2 (2007):161–170. PubMed ID: 17329296.

61 Holtmann M et al. Risperidone-associated ejaculatory and urinary dysfunction in male adolescents. Journal of Child and Adolescent Psychopharmacology 13.1 (2003):107–109. PubMed ID: 12804132.

62 Compton MT. Risperidone-induced ejaculatory disturbances. Psychiatric Services 53.3 (2002):347.

63 Rosenberg KP et al. A survey of sexual side effects among severely mentally ill patients taking psychotropic medications: impact on compliance. Journal of Sex & Marital Therapy 29.4 (2003):289–296. PubMed ID: 14504017.

64 Keller R et al. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia. Neurological Sciences 23.5 (2002):233–235. PubMed ID: 12522680.

65 Taylor DM et al. Atypical antipsychotics and weight gain – a systematic review. Acta Psychiatrica Scandinavica 101 (2000):416–432. PubMed ID: 10868465.

66 American Diabetes Association et al. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004; 27:596–601.

67 Gill SS et al. Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ 330.7489 (2005):445.

68 Gordon C et al. Do all relapses in schizophrenia warrant resumption of medication? The American Journal of Psychiatry 168.9 (2011):987. PubMed ID: 21890806.

69 Geddes JR et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. The Lancet 361 (2003):653–661. PubMed ID: 12606176.

70 O’Neill C. Scientists reveal how electroconvulsive therapy can help depression. The Independent 20 March 2012.

71 Zorumski CF et al. Electroconvulsive therapy for the elderly: a review. Hospital & Community Psychiatry 39.6 (1988):643–647. PubMed ID: 3042587.

72 van Beusekom BS et al. Long-term follow-up after successful electroconvulsive therapy for depression: a 4- to 8-year naturalistic follow-up study. The Journal of ECT 23.1 (2007):17–20. PubMed ID: 17435567.

73 Elkin I et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Archives of General Psychiatry 46.11 (1989):971–982.

74 Conte HR et al. Combined psychotherapy and pharmacotherapy for depression. A systematic analysis of the evidence. JAMA Psychiatry 43.5 (1986):471–479. PubMed ID: 3516110.

75 Paykel ES. Psychotherapy, medication combination and compliance. Journal of Clinical Psychiatry 56(suppl 1) (1995):24–30.

76 Loonen AJ. Continuation and maintenance therapy with antidepressive agents: meta-analysis of research. Pharmaceutisch weekblad 13 (1991):167–175. PubMed ID: 1834986.

77 Taylor D et al. The Maudsely Prescribing Guidelines (7th ed). London: Martin Dunitz; 2003. this resource:

78 Sternbach H. The serotonin syndrome. American Journal of Psychiatry 148 (1999):705–713. PubMed ID: 2035713.

79 Stahl SM. Stahl’s Essential Psychopharmacology. Neuroscientific Basis and Practical Applications (2nd ed). Cambridge: Cambridge University Press; 2000.Find this resource:

80 Larson EW et al. Organic causes of mania. Mayo Clinic Proceedings 63.9 (1988):906–912. PubMed ID: 3137394.

81 Sproule B. Lithium in bipolar disorder: can drug concentrations predict therapeutic effect? Clinical Pharmacokinetics 41.9 (2002):639–660. PubMed ID: 12126457.

82 Hawton K. Suicide risk and prevention in bipolar disorder. Psychiatr Danub 18 Suppl 1 (2006):33–34. PubMed ID: 16963886.

83 Brown EB et al. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. Journal of Clinical Psychiatry 67.7 (2006):1025–1033. PubMed ID: 16889444.

84 Schaffer A et al. Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression. Journal of Affective Disorders 96.1–2 (2006):95–99. PubMed ID: 16820213.

85 Lieberman JA et al. Antipsychotic drug effects on brain morphology in first-episode psychosis. Archives of General Psychiatry 62.4 (2005):361–370.

86 Cipriani A et al. Haloperidol alone or in combination for acute mania. Cochrane Database of Systematic Reviews 3 (2006):CD004362. PubMed ID: 16856043.

87 Kramlinger et al. ADDing lithium carbonate to carbamazepine: antimanic efficacy in treatment resistant mania. Acta Psychiatrica Scandinavica 79 (1989):378–385. PubMed ID: 2500006.

88 Miller DS et al. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania. Journal of Clinical Psychiatry 62 (2001):975–980. PubMed ID: 11780879.

89 Tohen M et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Archives of General Psychiatry 59 (2002):62–69.

90 Sachs GS. The Expert Consensus Guideline Series: medication treatment of bipolar disorder 2000. Postgraduate Medicine Special Issue (2000):1–104. PubMed ID: 10895797.

91 Compton MT. The treatment of bipolar depression. Journal of Clinical Psychiatry 61(Suppl 9) (2000):57–67. PubMed ID: 10826663.

92 Mukherjee S et al. Electroconvulsive therapy of acute manic episodes: a review of 50 years’ experience. American Journal of Psychiatry 151 (1994):169–176. PubMed ID: 8296883.

93 Sarris J et al. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. Journal of Clinical Psychiatry 73.1 (2012):81–86. PubMed ID: 21903025.

94 Ferriman A. Levels of neurosis remained static in the 1990s. BMJ 323 (2001):130. PubMed ID: 11463676.

95 Miller JJ et al. Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders. General Hospital Psychiatry 17.3 (1995):192–200. PubMed ID: 7649463.

96 Linden M et al. Efficacy of cognitive behaviour therapy in generalized anxiety disorders. Results of a controlled clinical trial (Berlin CBT-GAD Study). Psychotherapy and Psychosomatics 74.1 (2005):36–42. PubMed ID: 15627855.

97 Fisher PL. Recovery rates in generalized anxiety disorder following psychological therapy: an analysis of clinically significant change in the STAI-T across outcome studies since 1990. Psychological Medicine 29.6 (1999):1425–1434. PubMed ID: 10616949.

98 Ashton C Jr. Self-hypnosis reduces anxiety following coronary artery bypass surgery. A prospective, randomized trial. Journal of Cardiovascular Surgery (Torino) 38.1 (1997):69–75. PubMed ID: 9128126.

99 Rubio G et al. Generalized anxiety disorder: a 40-year follow-up study. Acta Psychiatrica Scandinavica 115.5 (2007):372–379. PubMed ID: 17430415.

100 Ogai M et al. A right orbitofrontal region and OCD symptoms: a case report. Acta Psychiatrica Scandinavica 111.1 (2005):74–76. PubMed ID: 15636597.

101 Ramsay R. Recent advances. Psychiatry. BMJ 311 (1995):167–170. PubMed ID: 7613431.

102 OCD with schizophrenia overlap. 2005.

103 Furukawa TA et al. Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia. Cochrane Database of Systematic Reviews 1 (2007):CD004364. PubMed ID: 17253502.

104 Baldwin D . Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group. British Journal of Psychiatry 175 (1999):120–126. PubMed ID: 10627793.

105 Liebowitz MR. Cognitive-behavioral group therapy versus phenelzine in social phobia: long-term outcome. Depression and Anxiety 1999;10(3):89–98. PubMed ID: 10604081. this resource:

106 Galea S. Psychological sequelae of the September 11 terrorist attacks in New York City. New England Journal of Medicine 346.13 (2002):982–987. PubMed ID: 11919308.

107 Villarreal G. Brain imaging in posttraumatic stress disorder. Seminars in Clinical Neuropsychiatry 6.2 (2001):131–145. PubMed ID: 11296313.

108 Chatterjee P. Mental health care for India’s tsunami survivors. The Lancet 365 (2005):833. PubMed ID: 15756722.

109 Pae CU et al. The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. International Clinical Psychopharmacology 23.1 (2008):1–8. PubMed ID: 18090502.

110 Stein DJ et al. Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database of Systematic Reviews 1 (2006):CD002795.

111 NICE. Post-traumatic stress disorder: management (CG26). NICE; 2005.

112 Simeon D. Feeling unreal: a PET study of depersonalization disorder. American Journal of Psychiatry 157.11 (2000):1782–1788. PubMed ID: 11058475.

113 Radford B. Pokemon contagion: photosensitive epilepsy or mass psychogenic illness? Southern Medical Journal 94.2 (2001):197–204. PubMed ID: 11235034.

114 Oakley DA. Hypnosis and conversion hysteria: a unifying model. Cognitive Neuropsychiatry 4.3 (1999):243–265. PubMed ID: 16571508.

115 Greyson B. Dissociation in people who have near-death experiences: out of their bodies or out of their minds? The Lancet 355 (2000):460–463. PubMed ID: 10841127.

116 Anonymous. Antidepressant discontinuation syndrome: update on serotonin reuptake inhibitors. Journal of Clinical Psychiatry 58(Suppl 7) (1997):3–40. No link available.Find this resource:

117 Lejoyeux M et al. Antidepressant withdrawal syndrome: recognition, prevention and management. CNS Drugs 5 (1996):278–292. No link available.Find this resource:

118 (Personal experience blog.)

119 Belloeuf L. Paroxetine withdrawal syndrome. Annales de Médecine Interne 151 Suppl A (2000):A52–53.

120 Black K. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. Journal of Psychiatry & Neuroscience 25.3 (2000):255–61. PubMed ID: 10863885.

121 de Vries ALC et al. Autism spectrum disorders in gender dysphoric children and adolescents. J Autism Dev Disord (2010):40, 930–936.Find this resource:

122 For a summary on attitudes towards transgender, lesbian, gay, and bisexual staff and patients within health and social care services in the UK see

123 Hatcher S et al. Problem-solving therapy for people who present to hospital with self-harm: Zelen randomised controlled trial. The British Journal of Psychiatry 199.4 (2011):310–316.

124 Morell S et al. The decline in Australian young male suicide. Social Science and Medicine 64.3 (2007):747–754. PubMed ID: 17079062.

125 Hawton K et al. Self-harm in England: a tale of three cities. Multicentre study of self-harm. Social Psychiatry and Psychiatric Epidemiology 42 (2007):513–521. PubMed ID: 17516016.

126 Sylvia Plath reads ‘A Birthday Present’: a rare 1962 recording.

127 Joy CB. Crisis intervention for people with severe mental illnesses. Cochrane Database of Systematic Reviews 2 (2000):CD001087. PubMed ID: 10796414.

128 Johnson S et al. Randomised controlled trial of acute mental health care by a crisis resolution team: the north Islington crisis study. BMJ 331 (2005):599–602.

129 Logullo F. Reversible combined cognitive impairment and severe polyneuropathy resulting from primary hyperparathyroidism. Italian Journal of Neurological Sciences 19.2 (1998):86–89. PubMed ID: 10935842.

130 Jick H. Statins and the risk of dementia. Lancet 356 (2000):1627–1631. PubMed ID: 11089820.

131 McCallum C et al. Sense of belonging and depressive symptoms among GLB adolescents. Journal of Homosexuality 58.1 (2010):83–96.

132 Tracy K et al. Utilizing peer mentorship to engage high recidivism substance-abusing patients in treatment. The American Journal of Drug and Alcohol Abuse 37.6 (2011):525–531.

133 Weeks GR. Toward a dialectical approach to intervention. Human Development 20.5 (1977):277–292.

134 Michael KD. How effective are treatments for child and adolescent depression? A meta-analytic review. Clinical Psychology Review 22.2 (2002):247–269. PubMed ID: 11806021

135 Weeks GR. Toward a dialectical approach to intervention. Human Development 20.5 (1977):277–292.

136 Ulloa RE et al. Psychosis in a pediatric mood and anxiety disorders clinic: phenomenology and correlates. Journal of the American Academy of Child & Adolescent Psychiatry 39.3 (2000):337–345.

137 Erkwoh R et al. [Imperative auditory hallucinations in schizophrenia]. Fortschritte der Neurologie-Psychiatrie 69.5 (2001):203–210.

138 Jenner JA et al. HIT, hallucination focused integrative treatment as early intervention in psychotic adolescents with auditory hallucinations: a pilot study. Acta Psychiatrica Scandinavica 103.2 (2001):148–152.

139 Hayden F. Long-term remission of schizophrenia in an adolescent treated with quetiapine. Journal of Child and Adolescent Psychopharmacology 11.3 (2001):289–293.

140 Nicolson R et al. Children and adolescents with psychotic disorder not otherwise specified: a 2-to 8-year follow-up study. Comprehensive Psychiatry 42.4 (2001):319–325.

141 Fremont WP. School refusal in children and adolescents. American Family Physician 68.8 (2003):1555–1568.

142 Bernstein GA et al. Treatment of school refusal: one-year follow-up. Journal of the American Academy of Child & Adolescent Psychiatry 40.2 (2001):206–213.

143 Galland BC et al. Mitchell. Helping children sleep. Archives of Disease in Childhood 95.10 (2010):850–853.

144 Oldani A et al. Autosomal dominant nocturnal frontal lobe epilepsy. Brain 121 (1998):205–223.

145 Bahro M et al. [REM sleep parasomnia]. Der Nervenarzt 65.8 (1994):568–571.

146 McConachie H et al. Parent implemented early intervention for young children with autism spectrum disorder: a systematic review. Journal of Evaluation in Clinical Practice 13.1 (2007):120–129.

147 Szatmari P et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nature Genetics 39.3 (2007):319–328.

148 Goldacre B. Bad Science. London: Fourth Estate; 2009.

149 Yoder P et al. Randomized comparison of two communication interventions for preschoolers with autism spectrum disorders. Journal of Consulting and Clinical Psychology 74.3 (2006):426–435. PubMed ID: 16822100.

150 University of Southampton. Research reveals early intervention provides key to increased IQ in children with autism. 2007.

151 Elvins R et al. Pharmacological management of core and comorbid symptoms in autism-spectrum disorder. Advances in Psychiatric Treatment 16.5 (2010):349–360.

152 Christison GW et al. Elimination diets in autism spectrum disorders: any wheat amidst the chaff? Journal of Developmental & Behavioral Pediatrics 27.2 (2006):S162–S171.

153 Faraone SV et al. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2.2 (2003):104.

154 Aman MG et al. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ. Journal of Child and Adolescent Psychopharmacology 14.2 (2004):243–254.

155 Lam LT. Attention deficit disorder and hospitalization owing to intra-and interpersonal violence among children and young adolescents. Journal of Adolescent Health 36.1 (2005):19–24.

156 NICE. Attention deficit hyperactivity disorder (Clinical Guideline 72). NICE; 2008.

157 Elia J et al. Treatment of attention-deficit–hyperactivity disorder. New England Journal of Medicine 340.10 (1999): 780–788.

158 Schachter HM et al. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. Canadian Medical Association Journal 165.11 (2001):1475–1488.

159 Messent PR. Primary and secondary barriers to physically active healthy lifestyles for adults with learning disabilities. Disability and Rehabilitation 21.9 (1999):409–419.

160 Mencap website:

161 Durana IL et al. A comparison of procedures for decreasing public disrobing of an institutionalized profoundly mentally retarded woman. Mental Retardation 18.4 (1980):185–188. PubMed ID: 7242354.

162 Lindsay WR et al. The treatment of men with a learning disability convicted of exhibitionism. Research in Developmental Disabilities 19.4 (1998):295–316.

163 McNally RJ et al. Behavioral treatment of zoophilic exhibitionism. Journal of Behavior Therapy and Experimental Psychiatry 22.4 (1991):281–284. PubMed ID: 1823663.

164 Clark LL et al. Learning disabilities within mental health services: are we adequately preparing nurses for the future? Journal of Psychiatric and Mental Health Nursing 14.5 (2007):433–437. PubMed ID: 17635250.

165 Gortmaker VJ et al. Improving reading outcomes for children with learning disabilities: using brief experimental analysis to develop parent-tutoring interventions. Journal of Applied Behavior Analysis 40.2 (2007):203–221. PubMed ID: 176 24063.

166 Investigation into the service for people with learning disabilities provided by Sutton and Merton Primary Care Trust. Healthcare Commission, 2007.

167 Ziora K et al. [Anorexia nervosa in boys and men.] Wiad Lek 59.5–6 (2006):352–358. PubMed ID: 17017481.

168 Rikani AA et al. A critique of the literature on etiology of eating disorders. Annals of Neurosciences 20.4 (2013):157–161.

169 Forbush K et al. Relationships between perfectionism and specific disordered eating behaviors. International Journal of Eating Disorders 40.1 (2007):37–41. PubMed ID: 16958125.

170 Ravaldi C et al. Eating disorders and body image disturbances among ballet dancers, gymnasium users and body builders. Psychopathology 36.5 (2003):247–254.

171 Sayin A et al. [A male anorexia nervosa case and its discussion from dynamic point of view.] Turk Psikiyatri Derg 15.2 (2004):155–160. PubMed ID: 15208771.

172 The British Psychological Society. Eating disorders: core interventions in the treatment and management of anorexia nervosa, bulimia nervosa and related eating disorders.

173 Millar HR et al. Anorexia nervosa mortality in Northeast Scotland, 1965–1999. American Journal of Psychiatry 162.4 (2005):753–757. PubMed ID: 15800149.

174 World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Geneva: WHO; 1992.

175 Mumford DB et al. Increased prevalence of bulimia nervosa among Asian schoolgirls. BMJ 297 (1988):718.

176 Carlat DJ et al. Eating disorders in males: a report on 135 patients. American Journal of Psychiatry 154.8 (1997):1127–1132. PubMed ID: 9247400.

177 Royal College of Psychiatrists. Primary care protocols for common mental illnesses. Protocol III: Eating disorders (18+ years) identification and referral. Royal College of Psychiatrists.

178 Hay PJ et al. Psychotherapy for bulimia nervosa and binging. Cochrane Database of Systematic Reviews 3 (2004):CD000562. PubMed ID: 15266434

179 Hsu LK. Outcome of bulimia nervosa. In Brownell KD (eds) Eating Disorders and Obesity. New York: Guildford Press; 1995, 238–246.

180 Kleinplatz PJ. Coming out of the sex therapy closet: using experiential psychotherapy with sexual problems and concerns. American Journal of Psychotherapy 61 (2007):333–348. PubMed ID: 17985534.

181 Crepault C et al. Men’s erotic fantasies. Archives of Sexual Behavior 9.6 (1980):565–581.

182 Melnik T et al. Psychosocial interventions for erectile dysfunction. Cochrane Database of Systematic Reviews 3 (2007):CD004825. PubMed ID: 17636774

183 McFarlane J et al. Intimate partner sexual assault against women: frequency, health consequences, and treatment outcomes. Obstetrics and Gynecology 105.1 (2005):99–108. PubMed ID: 15625149.

184 DeJong J. Reproductive health of Arab young people. BMJ 333 (2006):849–851.

185 Russell, ST et al. Adolescent sexual orientation and suicide risk: evidence from a national study. American Journal of Public Health 91.8 (2001):1276–1281.

186 Boyd M. Lucinda Brayford. 1952

187 Families and Friends of Lesbians and Gays (FFLAG) website:

188 Pollack R and Schwartz C in their book, The Journey Out: A guide for and about Lesbian, Gay, and Bisexual Teens. New York: Puffin; 1995. this resource:

189 Troth A et al. Factors predicting safe-sex talk and condom use in early sexual relationships. Health Communication 12.2 (2000):195–218. PubMed ID: 10938913.

190 London addresses: Family Planning: 2 Pentonville Rd, N1 9FP 0207 837 4044; Brook Centre: 165 Grays Inn Rd, WC1X 8UD; 0207 713 9000. Sex Education Forum: 8 Wakley Street, EC1V 7QE; Contraceptive Education Service 0207 837 4044.Find this resource:

191 Wisner KL et al. Clinical practice. Postpartum depression. New England Journal of Medicine 347 (2002):194–199. PubMed ID: 12124409.

192 Beck CT. The effects of postpartum depression on child development: a meta-analysis. Archives of Psychiatric Nursing 12.1 (1998):12–20.

193 Cummings EM. Maternal depression and child development. Journal of Child Psychology and Psychiatry 35.1 (1994):73–112.

194 McHug B. Fathers and postnatal depression.

195 Grube M. [Peripartum psychiatric disorders--support through men? A first approach]. Der Nervenarzt 75.5 (2004):483–488.

196 Cox JL et al. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry 150 (1987):782–786. PubMed ID: 3651732.

197 Westen D et al. The empirical status of empirically supported psychotherapies: assumptions, findings, and reporting in controlled clinical trials. Psychological Bulletin 130.4 (2004):631–663. PubMed ID: 15250817.

198 Weisz JR et al. Jousting with straw men: comment on Westen, Novotny, and Thompson-Brenner (2004). Psychological Bulletin 131.3 (2005):418–426, discussion 427–433. PubMed ID: 15869338.

199 Williams C et al. A cognitive behavioural therapy assessment model for use in everyday clinical practice. Advances in Psychiatric Treatment 8 (2002):172–179

200 Plaud JJ. Pavlov and the foundation of behavior therapy. Spanish Journal of Psychology 6.2 (2003):147–154. PubMed ID: 14628701.

201 Harris CV et al. An analysis of response prevention and flooding procedures in the treatment of adolescent obsessive compulsive disorder. Journal of Behavior Therapy and Experimental Psychiatry 23.2 (1992):107–15. PubMed ID: 1360985.

202 Granado LC et al. A spiderless arachnophobia therapy: comparison between placebo and treatment groups and six-month follow-up study. Neural Plasticity 2007 (2007):10241. PubMed ID: 17713595

203 Vaillant GE. Ego mechanisms of defense. A Guide for Clinicians and Researchers. Washington, DC: APA. ISBN 0-88048-404-7. this resource:

204 Pope KS et al. Sexual attraction to clients: the human therapist and the (sometimes) inhuman training system. American Psychologist 41.2 (1986):147–158.

205 Equus is a play by Peter Shaffer (1973) about a psychiatrist who attempts to treat a young man who has a religious/sexual fascination with horses.

206 Leichsenring F, Rabung S. Effectiveness of long-term psychodynamic psychotherapy: a meta-analysis. JAMA 300 (2008):1551–1565.Find this resource:

207 Molenaar PJ et al. Is there a dose-effect relationship between the number of psychotherapy sessions and improvement of social functioning? British Journal of Clinical Psychology 50.3 (2011):268–282. PubMed ID: 21810106.

208 Salvador Minuchin biography.

209 Tylee A. Counselling in primary care. The Lancet 350 (1997):1643.

210 Bower P. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. II: cost effectiveness. BMJ 321 (2000):1389–1392.

211 Ward E. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. I: clinical effectiveness. BMJ 321 (2000):1383–1388.

212 De Shazer S. Keys to Solution in Brief Therapy. New York: Norton; 1985. this resource:

213 Lancaster T. Individual behavioural counselling for smoking cessation. Cochrane Database of Systematic Reviews 2 (2000):CD001292. PubMed ID: 10796638.

214 Fukui S. A psychosocial group intervention for Japanese women with primary breast carcinoma. Cancer 89.5 (2000):1026–1036. PubMed ID: 10964333.

215 Smith LA et al. Therapeutic communities for substance related disorder. Cochrane Database of Systematic Reviews 1 (2006):CD005338. PubMed ID: 16437526.

216 Perry A et al. Interventions for drug-using offenders in the courts, secure establishments and the community. Cochrane Database of Systematic Reviews 3 (2006):CD005193. PubMed ID: 16856083.

217 Broekaert E et al. The third generation of therapeutic communities: the early development of the TC for addictions in Europe. European Addiction Research 2006; 12(1):1–11. PubMed ID: 16352897. this resource:

218 Joyce A. Insight and the nature of therapeutic action in the psychoanalysis of 4- and 5-year-old children. International Journal of Psychoanalysis 81 Pt 6 (2000):1139–1154.

219 Bratton S et al. The efficacy of play therapy with children: a meta-analytic review of treatment outcomes. Professional Psychology: Research and Practice 36.4 (2005):376–390.

220 Bolton P et al. Interventions for depression symptoms among adolescent survivors of war and displacement in northern Uganda: a randomized controlled trial. JAMA 298.5 (2007):519–527. PubMed ID: 1766667.

221 Hetzel-Riggin MD et al. A meta-analytic investigation of therapy modality outcomes for sexually abused children and adolescents: an exploratory study. Child Abuse & Neglect 31.2 (2007):125–141. PubMed ID: 17306369.

222 Allin H et al. Treatment of child neglect: a systematic review. Canadian Journal of Psychiatry 50.8 (2005):497–504. PubMed ID: 16127968.

223 Legoff DB et al. Long-term outcome of social skills intervention based on interactive LEGO play. Autism 10.4 (2006):317–329. PubMed ID: 16908476.

224 Keeling ML et al. Externalizing problems through art and writing: Experience of process and helpfulness. Journal of Marital and Family Therapy 32.4 (2006):405–419.

225 Massimo LM et al. In tribute to Luigi Castagnetta—drawings. Annals of the New York Academy of Sciences 1089.1 (2006):xvi–xxiii.

226 Ahmed SH et al. Essay: healing through art therapy in disaster settings. The Lancet 368  (2006):S28–S29.

227 Schmitt B et al. [Creative therapy options for patients with dementia--a systematic review]. Fortschritte der Neurologie-Psychiatrie 75.12 (2007):699–707.

228 Royal College of Psychiatrists, Royal College of General Practitioners. The management of patients with physical and psychological problems in primary care: a practical guide Report of a joint working group of the Royal College of General Practitioners and the Royal College of Psychiatrists.

229 Öster Inger RNT et al. Art therapy improves coping resources: a randomized, controlled study among women with breast cancer. Palliative & Supportive Care 4.01 (2006):57–64.

230 Top 10 art therapy myths. Art Therapy Spot blog.

231 Medical Protection Society. Capacity (competence) and capacity. MPS; 2014.

232 Jeste DV et al. Multimedia educational aids for improving consumer knowledge about illness management and treatment decisions: a review of randomized controlled trials. Journal of Psychiatric Research 42.1 (2008):1–21.

233 Feldman E. The Mental Health Act and common law. In Peveler R et al. (eds) Liaison Psychiatry: Planning Services for Specialist Settings. London: Gaskell; 2000.